MAPK3 and colitis: It was found that colonic epithelium had a significant decrease of both p-STAT3 and p-ERK1/2 at day 5 after DSS treatment, the administration of DFO during the early stage of colitis reserved the expression of p-STAT3 and p-ERK1/2.